Clicky

Articlesalley.com - Articles Directory

Browse Articles | Submit an Article | Search Articles | Most Viewed Articles | Latest Articles | FAQ
Article Directory
Articles Area
Home Login / Register Get RSS Feeds Add Free Article Content Article Ratings Go Daddy Coupon Codes
Guidelines
Authors Publishers
Home | Health-and-Fitness | Medicine | HSV-2 Infection ...

HSV-2 Infection

Submitted by vita and viewed 882 times
Total Word Count: 865  
Author Rating: NA

Rate this article Rate this article | Publisher Publisher | Print Print
HSV-2 antibodies do not routinely appear prior to adolescence, and antibody prevalence correlates with prior sexual activity. The primary route of acquisition of HSV-2 infections is via genital-genital sexual contact with an infected partner. HSVCurative is used specifically to treat HSV1 and HSV2 infections and acts as a curative agent against both these strains of herpes.

Currently, one-fifth of U.S. residents aged 12 years or older are infected with HSV-2 and one-quarter of U.S. residents aged 30 years or older are infected with HSV-2. These infection rates and their rise over the past two decades suggest that genital herpes is nearing epidemic proportions. HSV-2 antibodies do not routinely appear prior to adolescence, and antibody prevalence correlates with prior sexual activity.

The primary route of acquisition of HSV-2 infections is via genital-genital sexual contact with an infected partner. Since the late 1970s, seroprevalence rates for HSV-2 in the United States have increased by 30%, despite concurrent efforts associated with the human immunodeficiency virus epidemic to raise awareness of safer sex practices.

Predictors of positive HSV-2 serologic status include female sex, black race or Mexican-American ethnic background, a greater lifetime number of sexual partners, older age, less formal education, and an income below the poverty line. For sexually active Americans with a single lifetime sexual partner, the probability of acquisition of HSV-2 is 10.2%.

This figure increases to 20.7, 25.9, 30.9, and 46.1% as the number of lifetime sexual partners increases to 2 to 4, 5 to 9, 10 to 49, and over 50, respectively. Despite these high seroprevalence rates, only 2 to 3% of adults in the United States report ever having had genital herpes, and it is this lack of recognition of one's own infection which contributes to the surreptitious spread of the infection.

Along with the increased incidence of genital HSV-2 infections over the past two decades, there has also been a dramatic rise in the incidence of genital HSV-1 infections. Approximately 10% of cases of genital herpes in the United States were caused by HSV-1 in the early 1980s. By the mid-1990s, the percentage of primary cases of genital herpes caused by HSV-1 had doubled to 20%.

In other parts of the world, HSV-1 accounts for an even larger percentage of genital herpes cases, with rates in excess of 40% reported from Singapore, Sweden, England, Norway, and Japan. Genital HSV-1 infections can result from either genital-genital contact or oral-genital contact with an infected person who is actively shedding virus.

Given the decreased propensity of HSV-1 to reactivate at the genital site, however, it is oral-genital contact that accounts for most genital HSV-1 infections. Whites with genital herpes are more likely than blacks with genital herpes to have infection caused by HSV-1. This may relate to the younger ages at which orolabial HSV-1 infections are acquired among minorities, thereby providing a degree of protection against genital HSV-1 infection in adulthood.

HSVCurative is used specifically to treat HSV1 and HSV2 infections and acts as a curative agent against both these strains of herpes. It exhibits a pronounced anti-herpetic activity against HSV1 and HSV2 and, unlike other cures for herpes, actually kills these viruses upon exposure regardless of location on the body.

HSVCurative is formulated at maximum strength and has produced spectacular results above other potential herpes cures in eliminating herpes outbreaks in almost all known cases of use on herpes. It is possibly the most powerful and effective topical herpes treatment on the market, providing total clearance of outbreaks time after time.

Topical application causes herpes outbreaks to dissolve and dry out, with total clearance commonly experienced in 24 to 36 hours. This herpes cure gives immediate results and pain relief are certainly experienced with every application. HSVCurative is therefore proving to be the unrivaled cure for herpes in the treatment of oral and genital herpes.

HSVCurative contains certified organic medicinal plant extracts and antiviral essential oils which cause cellular death to HSV1 and HSV2 in scientific studies. HSVCurative has a rather remarkable array of pharmacological and biochemical properties which inactivate and destroy the herpes virus for unprecedented results compared to other cures for herpes.

The importance of applying certified organic material to outbreaks cannot be overstated. The herpes cure applied to lesions or open sores is quickly absorbed into the circulatory system in significant quantities; hence use of organic material is absolutely essential in herpes cures. HSVCurative is certified organic and is meant for medicinal use. To learn more, please go to http://www.bcured.net.

ArticleSource: ArticlesAlley.com
Additional articles about HSV
About the author
staff of Nature Power Company, which is a network company dedicated to promoting customers' websites and developing softwares. You can go to the following websites to learn more about our natural organic products. http://www.bcured.net http://www.naturespharma.org
Please Rate This Article

Number of ratings: 0
Rating: 0

© Copyright dd ArticlesAlley.com - All Rights Reserved Worldwide. About Us | Contact Us | Site Map | Exchange Links | Privacy Policy | Terms of Use